BK21 Biomolecule Research Initiative holds the International Symposium on Epigenomics Yonsei’s BK21 Biomolecule Research Initiative held the ‘International Symposium on Epigenomics: Revealing a New Aspect of Genome Regulation by DNA and Protein Modification’ on December 1st at the Yonsei Engineering building auditorium. Nobel Prize Laureate in Chemistry, Dr. Robert Huber (Max Planck Institute of Germany), and nine noted epigenomics scientists were invited to the event. Epigenomics, one of the areas which will be expected to lead biomedical science since the completion of the human genome project, was the main focus. The event was composed of nine epigenomics lectures dealing with three topics: Chromatin Modification, Frontier Approaches in Epigenomics, and Epigenetic Regulation in Cancer. Additionally, as a part of the Yonsei Nobel Forum program, Dr. Robert Huber, who received the 1988 Nobel Prize for Chemistry gave a special lecture on structural biology using X-ray crystallography. Following the lecture he participated in a discussion with undergraduate bioscience major students on the basic principles of protein structure crystallography. Dr. Huber also took part in an academic discussion with domestic structural biology professors and postgraduate students. The international symposium held by the BK21 Biomolecule Research Initiative and included participants such as famous scientists in the area of epigenomics from various countries including Kim Young-Jun (Yonsei University), Yoon Hong-Duk (Seoul National University), Doris Wagner (University of Pennsylvania, USA), Huck Hui NG (National University of Singapore, Singapore), Paul Lizardi (Yale University, USA), Jingde Zhu (Shanghai Cancer Institute, China), Kim Tae-Yoo (Seoul National University), Toshikazu Ushijima (National Cancer Center Research Institute, Japan), and Joseph F. Costello (University of California at San Francisco, USA). They shared the results on the latest research projects and discussed the trend of epigenomics studies in Korea. Over three hundred scientists from Korea and abroad took part in the event, and discussed plans for the Asian Epigenomics Research Consortium, which will be a part of the Human Epigenome Project by an international collaborated study.